Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line

Paul Morley, Sue MacLean, Tania D Gendron, Daniel L. Small, Roger Tremblay, Jon P. Durkin, Geoffrey Mealing

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The MIN6 pancreatic β-cell line responds to glutamate, α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, but not N- methyl-D-aspartate (NMDA) or 1S,3R-trans-ACPD, with increases in [Ca2+](i). This correlates with MIN6 expression of AMPA receptor subunits (GluR1-4) but only weak expression of NMDA NR2 receptor subunits, as determined by reverse transcriptase polymerase chain reaction (RT-PCR). Pharmacological characterization of the MIN6 AMPA receptors showed that AMPA-triggered [Ca2+](i) responses were blocked by GYKI 52466, 6-cyano-7-nitroquinoxaline- 2,3-dione (CNQX) and pentobarbital. AMPA-triggered [Ca2+ ](i) responses were also blocked in Na+-free medium and by the voltage-sensitive Ca2+ channel antagonist La3+. Unlike cortical neuronal cultures, which show a loss of membrane-associated protein kinase C (PKC) activity and die in response to excitatory amino acid exposure, glutamate was not toxic to MIM6 cells and it did not decrease PKC activity. These studies indicate that MIN6 cells possess Ca2+-impermeable AMPA receptors that secondarily allow Ca2+ influx following AMPA-induced depolarization and that, despite elevating [Ca2+](i), AMPA is not toxic to these cells. The effects of glutamate and glutamate receptor antagonists on pancreatic cells needs to be better understood if these compounds are to be used as therapeutic agents to treat stroke.

Original languageEnglish (US)
Pages (from-to)379-385
Number of pages7
JournalNeurological Research
Volume22
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Glutamate Receptors
Pharmacology
Cell Line
Glutamic Acid
AMPA Receptors
Poisons
Protein Kinase C
6-Cyano-7-nitroquinoxaline-2,3-dione
Excitatory Amino Acid Antagonists
Excitatory Amino Acids
Kainic Acid
Pentobarbital
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Reverse Transcriptase Polymerase Chain Reaction
Membrane Proteins
Stroke
Acids

Keywords

  • AMPA
  • Ca
  • MIN6
  • NMDA
  • Pancreas
  • Protein kinase C

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Morley, P., MacLean, S., Gendron, T. D., Small, D. L., Tremblay, R., Durkin, J. P., & Mealing, G. (2000). Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line. Neurological Research, 22(4), 379-385.

Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line. / Morley, Paul; MacLean, Sue; Gendron, Tania D; Small, Daniel L.; Tremblay, Roger; Durkin, Jon P.; Mealing, Geoffrey.

In: Neurological Research, Vol. 22, No. 4, 2000, p. 379-385.

Research output: Contribution to journalArticle

Morley, P, MacLean, S, Gendron, TD, Small, DL, Tremblay, R, Durkin, JP & Mealing, G 2000, 'Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line', Neurological Research, vol. 22, no. 4, pp. 379-385.
Morley, Paul ; MacLean, Sue ; Gendron, Tania D ; Small, Daniel L. ; Tremblay, Roger ; Durkin, Jon P. ; Mealing, Geoffrey. / Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line. In: Neurological Research. 2000 ; Vol. 22, No. 4. pp. 379-385.
@article{77943e5e92214bbab5ab051e1c767b73,
title = "Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line",
abstract = "The MIN6 pancreatic β-cell line responds to glutamate, α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, but not N- methyl-D-aspartate (NMDA) or 1S,3R-trans-ACPD, with increases in [Ca2+](i). This correlates with MIN6 expression of AMPA receptor subunits (GluR1-4) but only weak expression of NMDA NR2 receptor subunits, as determined by reverse transcriptase polymerase chain reaction (RT-PCR). Pharmacological characterization of the MIN6 AMPA receptors showed that AMPA-triggered [Ca2+](i) responses were blocked by GYKI 52466, 6-cyano-7-nitroquinoxaline- 2,3-dione (CNQX) and pentobarbital. AMPA-triggered [Ca2+ ](i) responses were also blocked in Na+-free medium and by the voltage-sensitive Ca2+ channel antagonist La3+. Unlike cortical neuronal cultures, which show a loss of membrane-associated protein kinase C (PKC) activity and die in response to excitatory amino acid exposure, glutamate was not toxic to MIM6 cells and it did not decrease PKC activity. These studies indicate that MIN6 cells possess Ca2+-impermeable AMPA receptors that secondarily allow Ca2+ influx following AMPA-induced depolarization and that, despite elevating [Ca2+](i), AMPA is not toxic to these cells. The effects of glutamate and glutamate receptor antagonists on pancreatic cells needs to be better understood if these compounds are to be used as therapeutic agents to treat stroke.",
keywords = "AMPA, Ca, MIN6, NMDA, Pancreas, Protein kinase C",
author = "Paul Morley and Sue MacLean and Gendron, {Tania D} and Small, {Daniel L.} and Roger Tremblay and Durkin, {Jon P.} and Geoffrey Mealing",
year = "2000",
language = "English (US)",
volume = "22",
pages = "379--385",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic β-cell line

AU - Morley, Paul

AU - MacLean, Sue

AU - Gendron, Tania D

AU - Small, Daniel L.

AU - Tremblay, Roger

AU - Durkin, Jon P.

AU - Mealing, Geoffrey

PY - 2000

Y1 - 2000

N2 - The MIN6 pancreatic β-cell line responds to glutamate, α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, but not N- methyl-D-aspartate (NMDA) or 1S,3R-trans-ACPD, with increases in [Ca2+](i). This correlates with MIN6 expression of AMPA receptor subunits (GluR1-4) but only weak expression of NMDA NR2 receptor subunits, as determined by reverse transcriptase polymerase chain reaction (RT-PCR). Pharmacological characterization of the MIN6 AMPA receptors showed that AMPA-triggered [Ca2+](i) responses were blocked by GYKI 52466, 6-cyano-7-nitroquinoxaline- 2,3-dione (CNQX) and pentobarbital. AMPA-triggered [Ca2+ ](i) responses were also blocked in Na+-free medium and by the voltage-sensitive Ca2+ channel antagonist La3+. Unlike cortical neuronal cultures, which show a loss of membrane-associated protein kinase C (PKC) activity and die in response to excitatory amino acid exposure, glutamate was not toxic to MIM6 cells and it did not decrease PKC activity. These studies indicate that MIN6 cells possess Ca2+-impermeable AMPA receptors that secondarily allow Ca2+ influx following AMPA-induced depolarization and that, despite elevating [Ca2+](i), AMPA is not toxic to these cells. The effects of glutamate and glutamate receptor antagonists on pancreatic cells needs to be better understood if these compounds are to be used as therapeutic agents to treat stroke.

AB - The MIN6 pancreatic β-cell line responds to glutamate, α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, but not N- methyl-D-aspartate (NMDA) or 1S,3R-trans-ACPD, with increases in [Ca2+](i). This correlates with MIN6 expression of AMPA receptor subunits (GluR1-4) but only weak expression of NMDA NR2 receptor subunits, as determined by reverse transcriptase polymerase chain reaction (RT-PCR). Pharmacological characterization of the MIN6 AMPA receptors showed that AMPA-triggered [Ca2+](i) responses were blocked by GYKI 52466, 6-cyano-7-nitroquinoxaline- 2,3-dione (CNQX) and pentobarbital. AMPA-triggered [Ca2+ ](i) responses were also blocked in Na+-free medium and by the voltage-sensitive Ca2+ channel antagonist La3+. Unlike cortical neuronal cultures, which show a loss of membrane-associated protein kinase C (PKC) activity and die in response to excitatory amino acid exposure, glutamate was not toxic to MIM6 cells and it did not decrease PKC activity. These studies indicate that MIN6 cells possess Ca2+-impermeable AMPA receptors that secondarily allow Ca2+ influx following AMPA-induced depolarization and that, despite elevating [Ca2+](i), AMPA is not toxic to these cells. The effects of glutamate and glutamate receptor antagonists on pancreatic cells needs to be better understood if these compounds are to be used as therapeutic agents to treat stroke.

KW - AMPA

KW - Ca

KW - MIN6

KW - NMDA

KW - Pancreas

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0034046898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034046898&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 379

EP - 385

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 4

ER -